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Abstract 
Many different studies have been conducted to determine the prevalence rates of Autism 
Spectrum Disorder (ASD) in the United States.  The methodologies of these studies have varied, 
resulting in a multitude of publications with differing prevalence rates. Because there is such a 
wide range in the results of prevalence studies, it may be difficult for individual states to 
determine their rates.  Accurate prevalence rates are important to obtain for many different 
reasons including increasing advocacy and awareness, increasing funding, and proper allocation 
of services for individuals with ASD and their families. Additionally, prevalence studies can be 
used to assess which groups are more at risk for ASD based off location and environmental 
factors.  This paper describes different methodologies that can be utilized to determine ASD 
prevalence rates, the strengths and weaknesses of each method, and the challenges to 
determining accurate rates. Implications for future prevalence studies will be addressed and 
recommendations will be provided.     
Keywords: autism, autism spectrum disorder, prevalence rates, intervention, decision-making 
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Autism Spectrum Disorder Prevalence Rates in the United States:  Methodologies, Challenges, 
and Implications for Individual States 
Autism Spectrum Disorder (ASD) is a developmental disorder that includes deficits in 
communication and social interactions and involves displaying repetitive patterns of behavior 
(CDC, 2012).  Individuals may receive a medical diagnosis of ASD and/or an educational 
verification of ASD. There are many differences between a medical diagnosis of ASD and an 
educational verification of ASD (Hawkins, 2009). A medical diagnosis is typically made by a 
physician, psychiatrist, licensed mental health practitioner, or clinical psychologist and is based 
off criteria from the Diagnostic Statistical Manual of Mental Disorders (DSM-V) of the 
American Psychological Association (Autism Society, 2015).  The medical criterion for ASD has 
significantly changed over time (European Commission, 2005; Saracino et al., 2010) to be more 
inclusive. More specifically, ASD is a term now used to include several related disorders 
including Autism, Asperger Syndrome, Pervasive Developmental Disorder- Not Otherwise 
Specified, Rett Syndrome, and Childhood Disintegrative Disorder (CDC, 2012). In the past 55 
years, the diagnostic criterion for ASD has changed at least six times. The first criterion utilized 
in the 1960s to diagnose ASD was known as Kanner’s Criteria (Saracino et al., 2010). This 
criterion changed in the 1970s to Lotter’s and Rutter’s criteria followed by the DSM-III (1980s), 
DSM-IV (1994), and the DSM-V (2013) (Fombonne, Quirke, & Hagen, 2009). These diagnostic 
changes involved expanding the criteria to define autism as a spectrum disorder that is broader in 
scope. These changes in definition have led to significant increases in prevalence rates over time.   
In contrast, an educational verification is made by a team of school professionals, known 
as a multidisciplinary team, using criteria from the Individuals with Disabilities Education Act 
(IDEA) (Hawkins, 2009). Educational verifications are used to determine if a child qualifies for 
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special education services. A medical diagnosis of ASD does not automatically qualify an 
individual to have an educational verification of ASD. Similarly, an educational verification of 
ASD does not mean a child will receive a medical diagnosis. The differences in medical and 
educational diagnoses are important to consider when determining the prevalence rates of ASD 
(Hawkins, 2009).  The purpose of this paper is to describe different methodologies that can be 
used to determine ASD prevalence rates, the strengths and weaknesses of each method, the 
challenges to determining accurate rates, and the implications for future prevalence studies.  We 
conclude by including a series of recommendations to those engaging in future ASD prevalence 
studies.  
Importance to Determining ASD Prevalence Rates 
Accurate prevalence rates are important to obtain for many reasons including increased 
advocacy and awareness, increased funding, and proper allocation of services for individuals 
with ASD and their families (Rice et al., 2012).  Additionally, prevalence studies can be used to 
assess which groups are more at risk for ASD based off location, and environmental factors 
(Rice et al., 2012).  Acquiring a more comprehensive understanding of these numbers may allow 
government agencies, nonprofit organizations, educational agencies, and philanthropists, to be 
better informed about how best to direct their efforts in helping individuals with autism receive 
the resources they need (Nonkin Avchen et al., 2011).  
Accurate prevalence rates may also have an impact on families who are need of 
additional services. While schools offer many supports for individuals with ASD, they do not 
always have the funding or resources to provide the necessary outside services to these 
individuals (Boswell, Zablotsky, & Smith, 2014). Families in need of additional resources often 
rely on the supports of outside agencies to enhance their children’s development. For example, 
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many families rely on programs that work with children when school is not in session and after 
graduation including transition and adult ASD programs. In order to be able to provide for these 
individuals, agencies must be able to accurately apply for funding and appropriately plan for 
ASD services (Boswell et al., 2014).  
Finally, accurate prevalence rates may help service organizations accurately plan for 
needed services (Boswell et al., 2014).  One commonality across prevalence studies over the 
years is reported increases in ASD prevalence rates (Fombonne, 2003).  Increased rates can have 
implications for service providers as they may be unprepared to meet the needs of a growing 
population of individuals with ASD (Bureau of Autism Services, 2009).  Knowing the number of 
individuals with ASD by location may help organizations determine where there is more need for 
ASD programs and where to allocate more funding (Boswell et al., 2014). 
Methodologies to Determining the Prevalence Rates of ASD 
Many different studies that have been conducted to determine the prevalence rates of 
ASD (Blumberg et al., 2013; Bureau of Autism Services in Pennsylvania, 2009; & CDC, 2012; 
2013).  The methodologies of these studies have varied, resulting in a multitude of publications 
with differing prevalence rates (Zaroff & Uhm, 2011).  Determining the true prevalence rates of 
ASD is challenging. The typical methodologies utilized to provide health information, such as 
health surveys and registries, are difficult to create (European Commission, 2005) and do not 
exist in most states throughout the United States.  Despite these difficulties, many studies have 
contributed to our knowledge of ASD prevalence rates. There are different methodologies to 
determining ASD prevalence rates including analyzing special education data, records review 
surveillance, surveys, and registries (Fombonne et al., 2009; Rice et al., 2012). Consumers need 
to be aware of these methodologies when utilizing prevalence rates so they understand the 
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limitations and implications of these studies (Fombonne et al., 2009). A more in depth 
understanding of methodologies can help consumers better interpret and appropriately utilize 
reported prevalence rates.   This section will review multiple prevalence methodologies and 
provide the benefits and limitations to these studies.  In all cases, these studies obtained informed 
consent from participants thereby following ethical guidelines as required by institutional review 
boards for research. 
The most common and widely cited ASD prevalence study is conducted by the Center for 
Disease Control and Prevention’s (CDC) Autism and Developmental Disabilities Monitoring 
Network (ADDM).  The ADDM Network has conducted multiple studies to determine the 
prevalence rates of Autism Spectrum Disorder (ASD) in the United States starting in 2000.  Data 
are collected using a records-review surveillance method which involves a review of professional 
evaluations of 8 year-old children from 11 sites in the United States (CDC, 2014).  These sites 
are located in Alabama, Arizona, Arkansas, Colorado, Georgia, Maryland, Missouri, New Jersey, 
North Carolina, Utah, and Wisconsin.  Examples of the evaluations that are reviewed include 
records from special education, pediatric health, psychologists, neurologists, psychiatrists, 
developmental pediatricians, physical therapists, etc.   The source files are then examined to 
determine if there are any ‘triggers’ for ASD documented in the records such as not interacting 
with others or receiving an ASD diagnosis (CDC, 2012).  Finally, each record is reviewed by 
trained individuals to determine if a child meets the qualifications for ASD under the DSM-IV.  
The CDC’s latest research study found the overall ASD prevalence rate to be 14.7 per 1,000 (1 in 
68) for children age 8 years old (CDC, 2014).  However, it is important to note that the 
prevalence rates vary when looking at each individual state (see Figure 1).  For instance, New 
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Jersey’s prevalence rates were 21.9 per 1,000 while Alabama’s rates were 5.7 in 1,000.  Both of 
which are markedly different from the overall ASD prevalence rate.     
 There are many benefits to using a screening method to determine ASD prevalence 
estimates.  For instance, the CDC’s method resulted in the identification of individuals who had 
not previously been diagnosed with ASD which may have led to more complete results.  Because 
more individuals are receiving classifications of ASD, the surveillance methodology often results 
in higher prevalence estimates (Rice et al., 2012).  The surveillance system helps to identify 
children who might have otherwise been missed due to the large variations in ASD symptoms 
(Nonkin Avchen et al., 2011).  The surveillance method may also provide more accurate 
prevalence rates compared to surveys based on parental reports or examinations of service 
provider registries because this method did not rely on a previously documented diagnoses.  
Additionally, it is more feasible to assess records than to screen each child individually (Nonkin 
Avchen et al., 2011).   
While there are many benefits to the ADDM data collection process, there are also 
limitations.  First, the data collected by the ADDM only includes 8 year-old children within 11 
sites (CDC, 2014).  In 2010, data started to be collected on 4 year-old children; however, this 
still leaves out a large number of children diagnosed with ASD.  For example, individuals who 
were diagnosed before and after age 8 would not be included in this study.  The surveillance sites 
included in the ADDM studies were not chosen to be representative of the United States or of the 
individual state where they are located (CDC, 2012).  Thus, using these numbers to identify ASD 
rates in the United States could be misleading.  Additionally, not all of the sites had access to 
educational records.  Only six out of nine sites in the 2010 ADDM surveillance data had access 
to educational records (CDC, 2014).  Educational records provide critical information on the 
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prevalence rates of ASD.  Lack of educational records would create a large underestimate of the 
prevalence of ASD because it would not include any child verified within the school system 
without a medical diagnosis. Another limitation is that the clinicians did not directly observe 
children to validate their diagnoses (Mandell & Lecavalier, 2014).  It is argued that the reviewers 
in this study were determining ASD diagnoses even though the community clinician may have 
already determined the child did not have an ASD diagnoses (Mandell & Lecavalier, 2014). 
Conversely, records surveillance methods may result in the same amount of false positives as 
true positives (Nonkin Avchen et al., 2011). 
Previous ASD Prevalence Rates Studies   
Despite the CDC’s limitations, their ASD studies are a vast improvement from previous 
methodologies in estimating ASD prevalence rates.  Prior to the CDC’s surveillance studies 
which began in 2000, the only data used to determine ASD national prevalence rates were state 
reports of the number of students ages 3-21 receiving special education services with an ASD 
verification (Shattuck, 2006).  The CDC’s method is arguably the best method for determining 
prevalence rates; however, it is very costly and time consuming.  This process may not be 
feasible for states to conduct due to funding and lack professional support.  States may decide to 
collect their own ASD prevalence rate data to make decisions based off the specific 
characteristics of their population (Boswell, Zablotsky, & Smith, 2014).  Studies have shown that 
ASD prevalence rates differ per state due to the heterogeneous sociodemographic variables of 
each state.  Even regions of a state can differ in prevalence because of differences in their 
population characteristics (Boswell, Zablotsky, & Smith, 2014).  This is why individual states 
should consider collecting information about their own state in place of using the rates of other 
states.   
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While many large scale studies have been conducted across the United States, individual 
states have done smaller scale prevalence studies.  The Bureau of Autism Services in 
Pennsylvania (2009) conducted a study using a records review system to determine the 
prevalence rates of ASD in Pennsylvania.  A records review system involves analyzing the data 
of individuals who have already been diagnosed with autism (Rice et al., 2012). Researchers 
gathered data from multiple institutions throughout the state including the Pennsylvania 
Departments of Public Welfare and Education, county services programs, children and youth 
offices, early intervention programs, behavioral health agencies, and the U.S. Department of 
Education’s Rehabilitation Services Administration.  Data from these agencies were merged by 
using identifiable information to ensure there was no duplication of records.  Results showed 
there were 19,862 individuals diagnosed with autism in the state of Pennsylvania in 2005.  Data 
was also collected from various counties and compared to the state-wide data.  Autism 
prevalence rates varied depending on the county with autism proportion rates ranging from .09% 
to .32% (Bureau of Autism Services, 2009). 
A benefit of the Bureau of Autism Services’ method was the collaboration that occurred 
across different organizations.  Collaboration is important and essential for this type of study to 
be conducted.  However, this can be a difficult process for states due to privacy regulations in the 
state.  Specific privacy regulations will be addressed in the following section. Another benefit to 
this method was that it can be utilized in future studies to assess trends in state-wide data over 
time.   It is also important to note the limitations of this study.  First, individuals not receiving 
ASD related services from these organizations and those who had not received formal diagnoses 
of ASD were not counted in these rates (Bureau of Autism Services in Pennsylvania, 2009).  
This can lead to a vast underestimation of individuals with ASD (Fombonne et al., 2009).  
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Furthermore, many adults with ASD were not included in the administrative datasets.  
Individuals with ASD who had an alternate primary diagnoses may have been missed. Another 
challenge with registries is that organizations may use difference assessment tools to diagnose 
ASD (Zaroff & Uhm, 2011).  For instance, using broad mental health measures may result in 
lower ASD prevalence rates compared to studies using ASD specific measurements for 
assessment purposes (Posserud, Lundervold, Lie, & Gillberg, 2010).  Also direct testing methods 
may vary depending on the testing and interview methods (Wong & Hui, 2008).  
The next prevalence methodology involves clinicians individually assessing a small 
population of individuals through multiple assessment tools to evaluate cognitive, adaptive, and 
social communication skills.  Nonkin Avchen and colleagues (2011) conducted a study to 
determine the ASD prevalence rates from a sample of 374 individuals.  Each individual was 
assessed by a trained clinician using the Differential Ability Scales, Vineland Adaptive Behavior 
Scales-II, the Social Communication Questionnaire, ADI-R, and the ADOS (Nonkin Avchen et 
al., 2011).  The advantage to this methodology is that clinicians were using the same assessment 
tools to determine ASD verifications.  However, prevalence studies that involve direct 
assessment of individuals typically result in higher estimates compared to studies based on 
previously existing records (Baron-Cohen et al., 2009).  Also, direct screening of individuals can 
be affected by low response rates and potential false screening results (Rice et al., 2012; Nonkin 
Avchen et al., 2011).  Individual assessments may provide accurate estimates; however, it is very 
time consuming and may not be feasible for a larger population (Nonkin Avchen et al., 2011).   
 The last prevalence methodology that will be addressed is survey methods.  Survey 
methods can be beneficial because they are relatively inexpensive, time effective, and are easy to 
administer.  Blumberg and colleagues (2013) conducted a study to determine the prevalence of 
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ASD by analyzing parent reports of school-age children. Data from the National Survey of 
Children’s Health (NSCH) was collected and analyzed to determine trends in ASD over time. 
The NSCH consists of a telephone survey for parents of children ages 0-17 in the United States.  
Children were determined to have an ASD diagnosis if their parent reported that their child had 
received a diagnosis from a doctor or other health care provider.  Results showed there was an 
increase in the ASD prevalence rates for children ages 6-17 from 2007 (1 in 86) to 2011-2012 (1 
in 50).  More specifically, there was a higher prevalence rate for individuals ages 14-17 in 2011-
2012 compared to 2007 (Blumberg et al., 2013).   
This survey methodology has the benefits of feasibility, time, and cost.  This method is 
much more feasible and less time consuming than the CDC process because all of the questions 
are conducted over the phone and individuals are not assessed using the DSM-IV TR.  It is also 
less expensive because the researchers did not need to hire professionals to diagnose individuals.  
While there are benefits to this method, there are also many limitations.  For instance, the 
prevalence estimates are prone nonresponse bias or parent bias in reporting ASD diagnoses.  
There was no evaluation of educational or medical reports to confirm these diagnoses (Blumberg 
et al., 2013). Additionally, these diagnoses were not all verified by the same professional.  There 
could have been professional errors or differences in the usage of ASD diagnostic criteria for 
these diagnoses.   
The Challenges to determining Autism Prevalence Rates 
As just reviewed, there are many differences in prevalence rates depending on the 
methodology of the study.  Each method presents challenges to determining accurate rates.  
Determining the prevalence rates of ASD in the United States can be complicated.  These 
complications may differ depending on the state.  The first challenge is that the diagnostic 
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criterion for ASD has significantly changed over time (Saracino et al., 2010).  These changes 
have had vast impacts on the prevalence estimates of ASD.  For instance, Kielinen et al. (2000) 
conducted a study to determine how a different diagnostic criterion affects overall ASD 
prevalence rates.  They applied different ASD  criteria to the same 39,216 children and found 
significant differences in prevalence rates.  For instance, when using Kanner’s diagnostic 
criteria, they found a prevalence rate of 2.3 per 10,000 children.  Next the researchers used the 
broader ICD-10 and DSM-IV ASD criteria and found a prevalence rate of 6.1 per 10,000.  
Finally, they used the ICD-10 criteria for ASD (PDD) and found a rate of 7.6 per 10,000 
children.  Thus, their results showed that broadening the ASD diagnostic criteria led to changes 
in the prevalence rates of ASD over time (Kielinen et al., 2000; Saracino et al., 2010).   
The next challenge is that professionals may differ in the way they apply the ASD 
diagnostic criteria, even though they may be using the same standards.  One reason this occurs is 
because of the impact of insurance coverage (Fombonne et al., 2009). Insurance agencies may 
play a role in the decision making process for determining whether a child qualifies under the 
ASD diagnostic criteria. While insurance coverage for ASD services is growing throughout the 
United States, many insurance agencies still do not cover treatment services for individuals with 
ASD (National Conference of State Legislatures, 2012).  Some states require insurance agencies 
to cover ASD treatment services while others argue this is the responsibility of parents or school 
systems. Others fear mandating insurance coverage for ASD would increase insurance premiums 
around 1 to 3 percent (Council for Affordable Health Insurance, 2009).  Currently, thirty-seven 
states have laws related to ASD insurance coverage.  Other states may have limited coverage 
under mental health coverage (National Conference of State Legislatures, 2012).  Because of the 
high cost of services for ASD, many parents cannot afford to pay for these services out of 
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pocket. The Harvard School of Public Health (2006) estimated it costs $3.2 million to care for an 
individual with ASD over his or her lifetime.  Thus, many parents request that clinicians 
diagnose their child with an alternate diagnoses related to ASD that is covered by insurance 
agencies.  In order to help these individuals receive services, many clinicians are using alternate 
diagnoses for ASD (Saracino et al., 2010).  
Relatedly, there are also differences in the way school teams verify ASD (Brock, 2006).  
The IDEA diagnostic criteria for ASD may be interpreted differently depending on the 
professional and on state regulations.  For instance, some multidisciplinary teams prefer to 
identify younger children with symptoms of ASD as developmentally delayed until the age of 9. 
The Individuals with Disabilities Education Improvement Act (2004) declared states may use 
either the disability categories for eligibility determinations or a verification of developmental 
delay for individuals ages birth through 9. Others may choose to verify the child with ASD at an 
earlier age. This is dependent on the members of the multidisciplinary team and state regulations.   
Additionally, many professionals substitute diagnostic categories within the school 
system (Brock, 2006; Fombonne et al., 2009).  Shattuck (2006) analyzed information from the 
Department of Education in the United States and found that professionals altered their 
diagnoses categories over the years.  For instance, from 1994 to 2003, autism prevalence rates 
increased from 0.6 to 3.1 per 1,000 while the prevalence rates for mental retardation and learning 
disabilities declined by 2.8 and 8.3 per 1,000 (Shattuck, 2006).  Brock (2006) also analyzed 
information from the United States Department of Education and found increased rates of 
Autism with lower rates of mental retardation, emotional disturbance, and specific learning 
disability.  Thus, perhaps increased school verifications of Autism are due to multidisciplinary 
teams using autism verifications instead of mental retardation, emotional disturbance, and 
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specific learning disability (Brock, 2006; California Department of Developmental Services, 
2003).   
Another challenge to determining prevalence rates is many states do not currently have a 
universal system of collecting data about individuals with ASD across organizations.  
Complications that make it difficult to collect data across organizations are medical and 
educational confidentiality and privacy regulations. Medical institutions follow confidentiality 
and privacy regulations set by the Health Insurance Portability and Accountability Act (HIPAA) 
(Department of Health and Human Services, 2003). The Department of Education follows the 
confidentiality regulations set by the Family Educational Rights and Privacy Act (FERPA) (U.S. 
Department of Education, 2015). To determine prevalence rates of ASD by previous diagnoses, 
researchers would need to access individually identifiable information such as name, date of 
birth, location, etc. (Bureau of Autism Services, 2009). Individually identifiable information 
would be required to cross reference medical and educational records to determine if an 
individual had a medical diagnosis, an educational verification, or both. In order to obtain 
records with identifiable information, HIPAA and FERPA regulations require that researchers 
obtain consent from each individual with ASD (Department of Health and Human Services, 
2003; U.S. Department of Education, 2015). Thus, researchers would need to obtain consent 
from thousands of individuals before they could gain access to their records to determine ASD 
prevalence rates. This process would also lead to inaccurate prevalence rates because many 
individuals may not respond to a consent request form.  Due to the requirement of HIPAA and 
FERPA to gain permission from individual families, it would not be feasible to access existing 
data in a state where there is no collaboration between different organizations serving individuals 
with ASD.  While HIPAA and FERPA are both extremely important components to protecting 
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confidentiality, they make it challenging for researchers to conduct an analysis of the prevalence 
rates across both medical and educational institutions. 
Implications and Recommendations 
There are many implications to using different methodologies in determining ASD 
prevalence rates.  For instance, prevalence rates vary depending on the methodology, research 
location, and regulations of the state.  Because there is such a wide range in the results of 
prevalence studies, it may be difficult for individual states to determine their rates.  Most states 
refer to the CDC study to estimate their prevalence rates, however, there is variability depending 
on the state.  Additionally, the CDC is potentially not representative of the states outside of the 
14 states that were analyzed in their study.  This poses the question, what prevalence rates can 
and should be utilized by these missing states?  Some may use the national rates published by the 
CDC while others may refer to the rates of states closest in proximity. The problem that arises 
when using rates of other states that are close in proximity is the fact that laws and regulations 
are different depending on the state.  For instance, ASD educational qualification criteria and 
insurance regulations may be different (Council for Affordable Health Insurance, 2009).  
Differences in insurance regulations can affect prevalence rates because lack of coverage tends 
to lead professionals to use alternate diagnoses (in order to get more coverage for ASD related 
services).  So if these differences are true, how can individual states determine ASD rates that are 
specific to their area?   
As previously described, there are many different methodologies that can be utilized to 
determine individual state prevalence rates of ASD such as replicating the CDC study for a 
smaller population that is representative of the state, administering a prevalence rate survey, or 
conducting individual assessments for a smaller representative sample.  (Fombonne et al., 2009).  
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It is recommended that the strengths and weaknesses of each methodology be analyzed before 
states make a decision on how to determine their ASD prevalence rates.  For instance, if 
choosing to create a registry, states need to be aware of the HIPAA and FERPA regulations that 
protect the confidentiality of individuals.  If they choose to conduct a parent survey, states need 
to be aware that their rates may be affected by nonresponse bias and are reliant on parent reports 
(Blumberg et al., 2013).  It is suggested that states become familiar with the challenges they may 
come across and create plans to address these concerns before choosing an appropriate 
methodology.   
Another recommended option is to create consistent data collection systems or registries 
to increase efficiency in determining prevalence rates each year.  It is suggested that states have 
similar data collection systems across agencies to improve communication and interpretation of 
data and to increase efficiency (Bureau of Autism Services, 2009).  It is also recommended that 
states link existing registries to other databases from service providers, medical institutions, or 
research institutions to further improve the accuracy of ASD prevalence rates (Rice et al., 2012).  
Finally, it is recommended that states and researchers focus on improving collaboration 
efforts of professionals and stakeholders (Rice et al., 2012).  Professionals can work to improve 
the communication between individuals with ASD and their families, researchers, service 
providers, and government officials about prevalence rates and the service needs of the 
community.  Organizations can create partnerships between public and private sources to support 
ASD research by increasing advocacy and research funding (Rice et al., 2012).     
Conclusion 
Researchers should continue to identify and utilize methodologies to accurately 
determine ASD prevalence rates.  One way to further enhance this effort is to collaborate with 
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other researchers and professionals who are conducting studies on the prevalence rates of other 
diagnoses (such as ADHD).  Studying these methodologies, in addition to the methodologies 
utilized in ASD prevalence studies, can provide researchers with more insight on how to conduct 
future studies (Rice et al., 2012).  Knowledge of the strengths and limitations of various 
methodologies as well as the anticipated challenges to an ASD prevalence study will help 
individual states to make more informed decisions and determine more accurate prevalence rates.   
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Figure 1. ASD Prevalence Rates from the 2010 CDC Study (published in 2014).   
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